anti-ROS1 (ROS1) 抗体产品概述

Full name:
anti-C-Ros Oncogene 1 , Receptor tyrosine Kinase 抗体 (ROS1)
在www.antibodies-online.cn可供186 C-Ros Oncogene 1 , Receptor tyrosine Kinase (ROS1) 抗体的12不同的供货商。 再加上,我们可以发ROS1 蛋白 (10)ROS1 试剂盒 (7)和数多这个蛋白质的别的产品。 总共207 ROS1产品已列进来了。
c-ros, c-ros-1, MCF3, ROS, Ros-1, ROS1C

最受欢迎的抗anti-ROS1 (ROS1) 抗体


抗Human ROS1 抗体:

抗Rat (Rattus) ROS1 抗体:

抗Mouse (Murine) ROS1 抗体:

所有可销售的anti-ROS1 抗体


引用最多的anti-ROS1 抗体

  1. Human Polyclonal ROS1 Primary Antibody for ELISA, WB - ABIN4242203 : Shiffman, Ellis, Rowland, Malloy, Luke, Iakoubova, Pullinger, Cassano, Aouizerat, Fenwick, Reitz, Catanese, Leong, Zellner, Sninsky, Topol, Devlin, Kane: Identification of four gene variants associated with myocardial infarction. in American journal of human genetics 2005 (PubMed)


Human C-Ros Oncogene 1 , Receptor tyrosine Kinase (ROS1) interaction partners

  1. Female, cribriform structure and presence of psammoma body were the three most powerful indicator of ROS1 rearrangement status, and predictive formula was helpful in screening ROS1-rearranged non-small-cell lung carcinomas, especially for ROS1 immunochemistry equivocal cases.

  2. report adds the ZCCHC8-ROS1 fusion as oncogenic driver in GBM and supports the role of ROS1 activation in the pathogenesis of a subset of glioblastoma

  3. ROS1 mutation is associated with response to chemotherapy in lung adenocarcinoma.

  4. A subset of ALK (显示 ALK 抗体)-negative inflammatory myofibroblastic tumour (IMT) have rearrangement of ROS1, ETV6 (显示 ETV6 抗体) or NTRK3 (显示 NTRK3 抗体) as a possible oncogenic mechanism.

  5. This review highlights treatment options, including clinical trials for ROS1 rearrangement, RET fusions, NTRK1 fusions, MET exon skipping, BRAF mutations, and KRAS mutations.

  6. High CEP85L-ROS1 expression is associated with neoplasms.

  7. 26 genes were found to fuse with ROS1 and different ROS1 fusions have distinct subcellular localization, suggesting that they may activate different substrates in vivo[review]

  8. ROS1-fusion genes act as a driver for the pathogenesis of lung adenocarcinoma.

  9. High prevalence of ROS1 copy number alterations are frequent in non-small cell lung cancer.

  10. our study suggested that the prevalence of ALK (显示 ALK 抗体), ROS1 and RET (显示 RET 抗体) fusions is very rare in lung squamous cell carcinoma patients.

Mouse (Murine) C-Ros Oncogene 1 , Receptor tyrosine Kinase (ROS1) interaction partners

  1. GPX1-dependent alterations in oxido-reductive stress promote ROS1 activation and mediate vascular remodeling.

  2. Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.

  3. c-ros and its ligand may be necessary for differentiation of epithelia I and II in mouse.

ROS1 抗原简介

Antigen Summary

This proto-oncogene, highly-expressed in a variety of tumor cell lines, belongs to the sevenless subfamily of tyrosine kinase insulin receptor genes. The protein encoded by this gene is a type I integral membrane protein with tyrosine kinase activity. The protein may function as a growth or differentiation factor receptor.

Alternative names and synonyms associated with ROS1

  • c-ros oncogene 1 , receptor tyrosine kinase (ROS1) 抗体
  • c-ros oncogene 1 , receptor tyrosine kinase (Ros1) 抗体
  • Ros1 proto-oncogene (Ros1) 抗体
  • c-ros 抗体
  • c-ros-1 抗体
  • MCF3 抗体
  • ROS 抗体
  • Ros-1 抗体
  • ROS1C 抗体

Protein level used designations for ROS1

c-Ros receptor tyrosine kinase , proto-oncogene c-Ros , proto-oncogene c-Ros-1 , proto-oncogene tyrosine-protein kinase ROS , receptor tyrosine kinase c-ros oncogene 1 , transmembrane tyrosine-specific protein kinase , v-ros UR2 sarcoma virus oncogene homolog 1 , v-ros avian UR2 sarcoma virus oncogene homolog 1 , Ros1 proto-oncogene , c-ros-1 , heart - derived c - ros - 1 proto - oncogene , proto-oncogene c-ros

6098 Homo sapiens
25346 Rattus norvegicus
396192 Gallus gallus
19886 Mus musculus
anti-ROS1 (ROS1) 抗体 精选生产商